ERA is in the process of being migrated to Scholaris, a Canadian shared institutional repository service (https://scholaris.ca). If you encounter any issues depositing to ERA, please contact erahelp@ualberta.ca
Communities and Collections
Usage
- 401 views
- 750 downloads
Addition of intravenous beta2-agonists to inhaled beta2- agonists for acute asthma
-
- Author(s) / Creator(s)
-
- Date created
- 2012
-
- Subjects / Keywords
-
- Child
- Adrenergic beta-2 Receptor Agonists/administration & dosage*
- Aminophylline/administration & dosage*
- Asthma/drug therapy*
- Administration, Inhalation
- Anti-Asthmatic Agents/adverse effects
- Adults
- Emergencies
- Adrenergic beta-2 Receptor Agonists/adverse effects
- Randomized Controlled Trials as Topic
- Bronchodilator Agents/adverse effects
- Anti-Asthmatic Agents/administration & dosage*
- Length of Stay
- Aminophylline/adverse effects
- Acute Disease Administration
- Heart Rate/drug effects
- Injections, Intravenous
- Bronchodilator Agents/administration & dosage*
- Humans
-
- Type of Item
- Review
-
- License
- Copyright © 2012 The Cochrane Collaboration. Published by JohnWiley & Sons, Ltd. This review is published as a Cochrane Review in the Cochrane Database of Systematic Reviews 2012, Issue 12. Cochrane Reviews are regularly updated as new evidence emerges and in response to comments and criticisms, and the Cochrane Database of Systematic Reviews should be consulted for the most recent version of the Review.